As the number of patients with thrombosis and thrombolysis increases, there is a critical need for clinicians to learn the latest scientific discoveries and treatment options. This timely Third Edition is a comprehensive text for cardiologists, hematologists, and pharmacologists in need of a resource on current agent development technology for treating cardiovascular and thromboembolic diseases.
New to the Third Edition:
a thorough examination of all the agents involved in treating thrombosis
chapters on biomarkers, testing, and pharmacogenomics
key topics, including new targets for antithrombotics, the development of novel classes of platelet inhibitors, new thrombolytic therapies, and evolving clinical uses of thrombolytics for ischemic stroke and venous thrombosis
the hemostatic and thrombotic pathways
New to the Third Edition:
a thorough examination of all the agents involved in treating thrombosis
chapters on biomarkers, testing, and pharmacogenomics
key topics, including new targets for antithrombotics, the development of novel classes of platelet inhibitors, new thrombolytic therapies, and evolving clinical uses of thrombolytics for ischemic stroke and venous thrombosis
the hemostatic and thrombotic pathways
Share This Book: